Sovaldi

  • The hepatitis C virus as it appears under a transmission electron microscope. Photo by BSIP/UIG Via Getty Images

    WASHINGTON — Your money or your life?

    Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.

    Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are gagging on the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi. Continue reading